Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,883,534 papers from all fields of science
Search
Sign In
Create Free Account
Breast Cancer Therapeutic Procedure
Known as:
Breast Cancer Treatment
, Breast Cancer, Treatment
Medical or surgical interventions to eradicate breast tumors and/or their metastases.
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Slingshot-1L, a cofilin phosphatase, induces primary breast cancer metastasis
Chen Chen
,
Y. Maimaiti
,
+4 authors
Huang Tao
OncoTarget
2017
Corpus ID: 247820
Slingshot (SSH) is a member of the conserved family of cofilin phosphatases that plays a critical role in cell membrane…
Expand
2016
2016
Prevalence of lymphedema after breast cancer treatment in overweight patients
Carina Batista de Paiva
,
C. Dutra
2016
Corpus ID: 115229725
263 Mailing address: Carina Batista de Paiva – Rua Henrique Dias, 24, Vila Torres Galvão –CEP Paulista (PE), Brazil – CEP: 53403…
Expand
Review
2013
Review
2013
Evaluation of Maximal Heart Rate Prediction Equations for Women During Breast Cancer Treatment: A Measurement Focused Study
J. Drouin
,
Lisa Birkmeier
,
K. Jones
,
S. L. Miller
,
Ronald L Gellish
,
B. Goslin
2013
Corpus ID: 81713209
Background: Maximal heart rate (HRmax) prediction equations based on age are commonly used for determining exercise test…
Expand
2012
2012
Breast-conserving surgery in breast cancer.
Tenea Cojan Ts
,
Vidrighin Cd
,
+6 authors
D. Mogoş
Chirurgia
2012
Corpus ID: 7716890
The breast cancer treatment is based nowadays on new surgical options: breast-conserving surgery, which applies at least for the…
Expand
2012
2012
Role of HER2 signaling pathway in breast cancer: biology, detection and therapeutical implications
N. D. Plavetić
,
A. Kulić
,
D. Vrbanec
2012
Corpus ID: 9189990
Human epidermal growth factor receptor 2 (HER2), a member of the ErbB family of transmembrane receptor tyrosine kinases, is…
Expand
2011
2011
Phase I trial of veliparib, (ABT-888), a poly(ADP-ribose) polymerase (PARP) inhibitor, in combination with doxorubicin and cyclophosphamide in breast cancer and other solid tumors.
Antoinette R. Tan
,
D. Toppmeyer
,
+9 authors
R. DiPaola
Journal of Clinical Oncology
2011
Corpus ID: 13552359
3041 Background: Veliparib is a potent, oral inhibitor of PARP-1 and PARP-2. We previously reported phase I results of veliparib…
Expand
2010
2010
Histopathologic study of the Antiestrogenic Nolvadex Induced Liver Damage in Rats and Vitamins Ameliorative Effect
F. Morsy
,
A. G. E. Din
,
Nermeen M. Shaffie
,
M. Badawi
2010
Corpus ID: 212604329
This study was designed to evaluate the effects of antiestrogenic Nolvadex (used for breast cancer treatment) on rat liver and…
Expand
2007
2007
UPPER LIMB LYMPHEDEMA FOLLOWING BREAST CANCER SURGERY : PREVALENCE AND ASSOCIATED FACTORS
Bergmann
2007
Corpus ID: 184481673
Introduction: Lymphedema is one of the main complications following breast cancer surgery, and affects the quality of life of…
Expand
2002
2002
Erfolge und Komplikationen der brusterhaltenden Mammakarzinomtherapie: Ergebnisse einer Langzeitbeobachtung
B. Strobl
,
W. Janni
,
+5 authors
T. Dimpfl
2002
Corpus ID: 71214384
Purpose: Over the last decades, breast conserving therapy increasingly occupied a leading role in breast cancer treatment…
Expand
1980
1980
Comparison of tamoxifen and hypophysectomy in breast cancer treatment
MD DAVID T. KIANG
,
D. H. Phd
,
G. J. Md
,
MD J. KENNEDY
Cancer
1980
Corpus ID: 42915144
The effectiveness of hypophysectomy and tamoxifen in treating advanced breast cancer was compared in a randomized study of 26…
Expand